MDxHealth
0479.292.440 · rovalta.com · 26/09/2026
MDxHealth
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOMDxHealth is a Public limited company incorporated in 2003. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Herstal.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0479.292.440
- Incorporation
- 15/01/2003
- Legal form
- Public limited company
- Registered office
- Rue d'Abhooz 31
4040 Herstal · WallonieSee on map - Contributed capital
- 334 592 333,35 €
- Latest accounts
- 31/12/2025
- Average workforce
- 0,0 ETP
Joint committees (2)
- 30502
- 33004
Financials
Source · NBB, 24 filingsTrend over 20 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 4,2 M € | +6.3% | 3,9 M € | +23.4% | 3,2 M € | +7.8% | 2,9 M € | -21.2% | 3,7 M € |
| EBITDA | -7,6 k € | +99.8% | -3,2 M € | +41.7% | -5,5 M € | +34.3% | -8,4 M € | -53.3% | -5,5 M € |
| Operating result | -4,3 M € | +26.4% | -5,9 M € | +21.7% | -7,5 M € | +19.1% | -9,3 M € | -67.7% | -5,5 M € |
| Net result | -4,1 M € | -159% | 7 M € | +125% | -28,4 M € | +40.7% | -47,8 M € | -550% | -7,4 M € |
| Balance sheet | |||||||||
| Equity | 134 M € | -0.2% | 134,3 M € | +53.8% | 87,3 M € | +16.5% | 74,9 M € | -36.4% | 117,8 M € |
| Total assets | 159,3 M € | -8.8% | 174,7 M € | +29.9% | 134,4 M € | +7.8% | 124,7 M € | -8.4% | 136,1 M € |
| Cash | 20,3 M € | -52.5% | 42,8 M € | +127% | 18,9 M € | +59.3% | 11,8 M € | -76.3% | 49,9 M € |
| Debts | 19,1 M € | -14.2% | 22,3 M € | -36.3% | 35 M € | -2.9% | 36 M € | +219% | 11,3 M € |
| Other | |||||||||
| Workforce | 0,0 ETP | -100% | 1,0 ETP | -33.3% | 1,5 ETP | -42.3% | 2,6 ETP | 0.0% | 2,6 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20258 active · 119 ended
Active mandates
Ended mandates
Other companies at this address
Rue d'Abhooz 31 4040 Herstal| Company | CBE no. |
|---|---|
A&T EFFICIENCY● Active | 0724.982.849 |
Atvisor● Active | 1026.069.760 |
CAP MULTI SERVICES● Active | 0894.100.270 |
CAP PURCHASING SOLUTIONS● Active | 0472.586.671 |
CR OUTDOOR INTL● Active | 0804.523.740 |
Danly Europ S.A.● Active | 0412.633.248 |
Deluxe Belgium● Active | 0738.723.393 |
DISA● Active | 0429.979.818 |
DM Belgium● Active | 0769.894.938 |
D.T.L.G.● Bankrupt | 0462.731.174 |
EELIX● Active | 0666.419.197 |
EQUIP'● Active | 0451.141.852 |
EVEILLATION● Bankrupt | 0795.478.786 |
FORDIBEL● Active | 0870.674.077 |
GLOBAL CRANES● Active | 0891.971.220 |
H AUB● Active | 0788.415.802 |
JIM CONSULTING & SERVICES● Active | 0768.234.753 |
KBOSS & KO● Active | 0799.442.227 |
LE STUDIO 17 PHOTOGRAPHIE● Active | 0680.577.437 |
LIEGEOISE DE DEMANTELEMENT● Liquidation | 0634.841.046 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 06/07/2026 | 17/06/2025 | 20/06/2024 | 30/05/2023 | 30/05/2022 | 27/05/2021 |
| General meeting | 28/05/2026 | 28/05/2025 | 30/05/2024 | 25/05/2023 | 25/05/2022 | 27/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 24 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 28/05/2026 | 06/07/2026 | French | |
| Full model | 31/12/2024 | 28/05/2025 | 17/06/2025 | French | |
| Consolidated accounts | 31/12/2024 | 28/05/2025 | 23/06/2025 | French | |
| Full model | 31/12/2023 | 30/05/2024 | 20/06/2024 | French | |
| Consolidated accounts | 31/12/2023 | 30/05/2024 | 21/06/2024 | French | |
| Full model | 31/12/2022 | 25/05/2023 | 30/05/2023 | French | |
| Consolidated accounts | 31/12/2022 | 25/05/2023 | 20/12/2023 | French | |
| Full model | 31/12/2021 | 25/05/2022 | 30/05/2022 | French | |
| Consolidated accounts | 31/12/2021 | 25/05/2022 | 20/12/2023 | French | |
| Full model | 31/12/2020 | 27/05/2021 | 27/05/2021 | French | |
| Full model | 31/12/2019 | 28/05/2020 | 29/05/2020 | French | |
| Full model | 31/12/2018 | 29/05/2019 | 04/06/2019 | French | |
| Full model | 31/12/2017 | 31/05/2018 | 04/06/2018 | French | |
| Full model | 31/12/2016 | 26/05/2017 | 29/05/2017 | French | |
| Full model | 31/12/2015 | 27/05/2016 | 30/05/2016 | French | |
| Full model | 31/12/2014 | 29/05/2015 | 01/06/2015 | French | |
| Full model | 31/12/2013 | 30/05/2014 | 05/06/2014 | French | |
| Full model | 31/12/2012 | 31/05/2013 | 03/06/2013 | French | |
| Full model | 31/12/2011 | 25/05/2012 | 11/06/2012 | French | |
| Full model | 31/12/2010 | 27/05/2011 | 07/06/2011 | French | |
| Full model | 31/12/2009 | 28/05/2010 | 18/06/2010 | French | |
| Full model | 31/12/2008 | 29/05/2009 | 22/06/2009 | French | |
| Full model | 31/12/2007 | 30/05/2008 | 19/06/2008 | French | |
| Full model | 31/12/2006 | 25/05/2007 | 21/06/2007 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 100 M€ and 250 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20258 active · 119 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Capital / shares17/09/2026CAPITAL, ACTIONS
- Mandates10/07/2026DEMISSIONS, NOMINATIONS
- Other30/06/2026DIVERS
- Capital / shares22/10/2025CAPITAL, ACTIONS
- Mandates06/10/2025DEMISSIONS, NOMINATIONS
- Other25/07/2025DIVERS
- Capital / shares13/11/2024STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
- Capital / shares18/10/2024STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-4,1 M €↓
- 01/10/2025augmentation_capital
- 01/10/2025apport
- 28/05/2025reconductionDonnie M. Hardison Jr. — administrateur
- 28/05/2025reconductionHilde Windels BV — administrateur
- 28/05/2025reconductionEric Bednarski — administrateur
- 28/05/2025nominationMichael Brian Holder — administrateur
- 2024Annual accounts 20247 M €↑
- 29/10/2024augmentation_capital
- 27/09/2024augmentation_capital
- 27/09/2024augmentation_capitalGenomic Health, Inc.
- 06/07/2024reconductionDr. Sanford Jay Siegel — administrateur
- 06/07/2024nominationDr. Sanford Jay Siegel — administrateur
- 30/05/2024reconductionAhok BV — administrateur
- 30/05/2024reconductionQaly-Co BV — administrateur
- 2023Annual accounts 2023-28,4 M €↑
- 13/11/2023reduction_capital
- 20/10/2023augmentation_capital
- 25/05/2023reconductionHilde Windels — administrateur indépendant
- 25/05/2023reconductionRegine Slagmulder — administrateur indépendant
- 25/05/2023reconductionEric Bednarski — administrateur
- 25/05/2023reconductionMichael K. McGarrity — administrateur
- 25/05/2023reconductionBert Kegels — commissaire
- 08/03/2023augmentation_capital
- 07/02/2023augmentation_capital
- 2022Annual accounts 2022-47,8 M €↓
- 11/08/2022augmentation_capital
- 11/08/2022apport
- 25/05/2022augmentation_capital
- 2021Annual accounts 2021-7,4 M €↓
- 2020Annual accounts 2020-1,5 M €↑
- 2019Annual accounts 2019-111,4 M €↓
- 2018Annual accounts 2018505,7 k €↓
- 2017Annual accounts 201712 M €↑
- 2016Annual accounts 20163,7 M €↑
- 2015Annual accounts 2015-958,3 k €↑
- 2014Annual accounts 2014-1,1 M €↑
- 2013Annual accounts 2013-2,9 M €↓
- 2012Annual accounts 2012-2,7 M €↑
- 2011Annual accounts 2011-6,8 M €↑
- 2010Annual accounts 2010-8,9 M €↑
- 2010Name changeMDxHealth
- 2009Annual accounts 2009-16,1 M €↓
- 2008Annual accounts 2008-8,9 M €↑
- 2007Annual accounts 2007-9,1 M €↑
- 2006Annual accounts 2006-9,3 M €
- 2006Name changeONCOMETHYLOME SCIENCES
- 15/01/2003IncorporationPublic limited company